FDAnews Device Daily Bulletin

NIH-SPONSORED MACROLIDE AZITHROMYCIN COPD PHASE III STUDY UTILIZES MED-IC SMART BLISTER PACKAGING

Dec. 12, 2005
A A

Information Mediary Corporation has begun to supply over 30,000 of its Med-ic RFID smart sensor labels for use in a large multi-year COPD macrolide study. The study, sponsored by NIH's National Heart, Lung, and Blood Institute (NHLBI) will be enrolling over 1100 patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), with emphasis on the prevention and management of exacerbations of the disease.

MoreRFID (http://www.morerfid.com/details.php?subdetail=Report&action=details&report_id=1023&display=RFID)